bioenergetics

Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.

ProAX is an AXP prodrug that enhances intracellular ATP levels without causing cytotoxicity. It is metabolized by intracellular enzymes such as esterases and phosphoamidases, converting it into AMP, ADP, and ATP. ProAX has potential applications in the study of bioenergetics and molecular therapy.

3-Hydroxy Palmitic Acid is a saturated fatty acid containing 16 carbon atoms with a hydroxyl group at the 3-position. Its main functions include serving as a biomarker for endotoxin (lipid A) and as a quorum-sensing signaling molecule in bacteria. Additionally, this compound accumulates and causes toxicity in certain mitochondrial metabolic defects.

PDK-IN-2 (Compound 1F), with an IC50 of 68 nM, is a potent PDK inhibitor that downregulates the expression of PDK1 and PDK4 in cells. It promotes mitochondrial bioenergetics, reduces glycolytic activity, and triggers apoptosis via the mitochondrial pathway. Additionally, PDK-IN-2 has been shown to impede tumor growth in a 4T1 syngeneic mouse model [1].

PDK4-IN-2 (compound 8), a pyruvate dehydrogenase kinase 4 (PDK4) inhibitor, exhibits an inhibition concentration (IC 50) of 46 µM. By regulating bioenergetics and activating the tricarboxylic acid cycle [1], it enhances the ejection fraction in failing hearts.

Glyburide-D3 is the deuterated form of Glyburide (TMSM-1266). Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor, utilized in the research of diabetes and obesity. It inhibits P-glycoprotein, directly binds to and blocks the SUR1 subunit of KATP, and suppresses the cystic fibrosis transmembrane conductance regulator (CFTR). Additionally, Glibenclamide interferes with mitochondrial bioenergetics by inducing membrane ion permeability and can induce autophagy.

Glyburide-D11 is a deuterated form of Glyburide (TMSM-1266). Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor used in the study of diabetes and obesity. It inhibits P-glycoprotein and directly binds to block the SUR1 subunit of KATP, also inhibiting cystic fibrosis transmembrane conductance regulator (CFTR). Glibenclamide interferes with mitochondrial bioenergetics by inducing membrane ion permeability and can induce autophagy.

Glibenclamide (Standard) is the analytical reference standard of Glibenclamide intended for research and quantitative applications, and as an orally active ATP-sensitive potassium channel inhibitor, Glibenclamide directly binds SUR1 subunits of KATP channels, inhibits P-glycoprotein and CFTR, alters mitochondrial membrane ion permeability, induces autophagy, and supports research in diabetes, obesity, and cellular bioenergetics.

Bid BH3 peptide, a small peptide derived from the Bid protein, binds to and activates the pro-apoptotic proteins Bax and Bak, leading to mitochondrial outer membrane permeabilization (MOMP) and cell apoptosis (apoptosis). This peptide is utilized in research on mitochondrial bioenergetics.